Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rescue chemotherapy with mitomycin + ifosfamide in metastatic pancreatic adenocarcinoma (phase II)
2006-001163-29Phase 2Terminated
- Sponsor
- IRCCS Ospedale San Raffaele
- Start
- Mar 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of mitomycin c and ifosfamide in pancreatic adenocarcinoma (PDAC), sponsored by IRCCS Ospedale San Raffaele. Primary endpoint: PF5-6. Started Mar 2006; status: terminated.
02
Drugs
mitomycin cifosfamide
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on 2006-001163-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001163-29.